Barclays PLC Increases Position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Barclays PLC increased its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 80.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 122,689 shares of the company’s stock after acquiring an additional 54,557 shares during the period. Barclays PLC owned about 0.06% of Aveanna Healthcare worth $637,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Geode Capital Management LLC grew its stake in Aveanna Healthcare by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock valued at $7,287,000 after purchasing an additional 63,190 shares during the period. State Street Corp grew its position in Aveanna Healthcare by 0.9% during the third quarter. State Street Corp now owns 1,039,920 shares of the company’s stock valued at $5,408,000 after buying an additional 9,446 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Aveanna Healthcare by 3.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock worth $2,406,000 after buying an additional 17,522 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its position in Aveanna Healthcare by 297.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock worth $1,848,000 after acquiring an additional 265,969 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock valued at $438,000 after acquiring an additional 96,600 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Stock Performance

Shares of AVAH opened at $4.70 on Friday. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.00 and a fifty-two week high of $6.19. The business has a 50-day moving average of $5.12 and a 200 day moving average of $4.79. The firm has a market cap of $908.18 million, a P/E ratio of -13.82 and a beta of 2.25.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. The business had revenue of $509.02 million during the quarter, compared to the consensus estimate of $495.80 million. During the same period last year, the firm earned ($0.05) EPS. As a group, research analysts predict that Aveanna Healthcare Holdings Inc. will post -0.07 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a research note on Monday, January 6th.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.